Radiopharmaceutical;radioligand;theranostics;CA9;MD Anderson Cancer Center

MD Anderson and C-Biomex sign collaborative research agreement to co-develop CBT-001 radioligand therapy

[ad_1] Newswise — HOUSTON & POHANG, South Korea – The University of Texas MD Anderson Cancer Center and C-Biomex Ltd. today…